Designed to rebuild.
Straumann® EmdogainTM

Straumann Emdogain supports the predictable regeneration of lost periodontal hard and soft tissue.

Clinical photos courtesy of Prof. Zuchelli, Bologna University
8 months post-op

Radiograph indicates a deep intrabony defect
Case courtesy of Dr. Donald S. Clem, Fullerton, CA
12 months post-op

Straumann Emdogain is an easy-to-apply, protein-based gel that is designed to promote predictable regeneration of lost periodontal hard and soft tissues caused by periodontitis, helping to save and preserve the tooth.1   Easy to apply with prefilled syringes, it is convenient to use and easily integrated into periodontal surgery.

Clinical Benefits

  • Demonstrated safe and effective in stimulating the formation of new periodontal attachment (periodontal ligament, cementum and alveolar bone)
  • More than 400 clinical publications demonstrating predictable results, including results up to 10 years 2,3
  • More than 1 million patients treated worldwide*
  • Familiar surgical procedure and easy application of material to the surgical site

Practice Benefits

  • Creates new treatment opportunities and revenue stream
  • Creates value to your GPs and your patients
  • Early treatment can achieve predictable4, long-lasting results2
  • Helps position you as a clinician who offers excellent long-term options and results 3,5
  • Cost effective treatment option with a smaller volume (0.15 ml)

Patient Benefits

  • Produces natural-looking results5
  • Helps restore patients’ self-confidence
  • Enhanced periodontal wound healing, as reported by clinicians
  • Helps patients preserve their smile
  • Less pain and discomfort**5

*Based on units sold
**Compared to CTG

"Straumann® Emdogain stimulates the regeneration of both the hard and soft tissues of the periodontium at the same time.” 

-Dr. David Cochran

View our entire implant portfolio in the eShop.

See how emdogain regenerates the periodontium

Saving teeth with Emdogain

Biological Guided Regeneration for Various Indications

Straumann Emdogain has documented clinical results in intrabony defects, recession defects, or furcation defects, either alone or with bone graft materials,** such as Straumann AlloGraft.

**Allograft, autograft, bone-derived xenograft, beta-TCP or bioactive glass.

Recession Defects

Intrabony Defects

Furcation Defects

1 Bosshardt DD. Biological mediators and periodontal regeneration: a review of enamel matrix proteins at the cellular and molecular levels. J Clin Periodontol. 2008 Sep;35(8 Suppl):87-105.

2 Sculean A, Kiss A, Miliauskaite A, Schwarz F, Arweiler NB, Hannig M. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol. 2008 Sep;35(9):817-24. Epub 2008 Jul 21.

3 McGuire MK, Scheyer ET, Nunn M. Evaluation of human recession defects treated with coronally advanced flaps and either enamel matrix derivative or connective tissue: comparison of clinical parameters at 10 years. J Periodontol. 2012;83:1353-1362.

4 Miller PD. A classification of marginal tissue recession. Int J Periodontol Rest Dent. 1985;5,8-135 Parashis, AO et al. Enamel Matrix Derivative in Intrabony Defects. Prognostic Parameters of Clinical and Radiographic Treatment Outcomes. J Periodontol 2012: epub ahead of print.

5 McGuire, MK & Nunn, M. Evaluation of human recession defects treated with coronally advanced flaps and either enamel matrix derivative or connective tissue. Part 1: Comparison of clinical parameters. J Periodontol 2003;74:1110–1125

6 Jepsen S, Heinz B, Jepsen K, Arjomand M, Hoffmann T, Richter S, Reich E, Sculean A, Gonzales JR, Bödeker RH, Meyle J. A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal Class II furcation involvement in mandibular molars. Part I: Study design and results for primary outcomes. J Periodontol. 2004 Aug;75(8):1150-60.